Diabetes and development of tardive dyskinesia
American Journal of PsychiatryPublished 1 June 1993
Margaret G. Woerner, Bruce L. Saltz, John M. Kane, J.A. Lieberman, José Alvir
Citations75
SJR quartileQ1
SJR score5.27
SNIP3.68
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The authors examined 160 elderly individuals who were beginning neuroleptic treatment; 24 had diabetes and 136 did not, and the cumulative incidence rates of tardive dyskinesia were 54.1% (SE = 5.6%) for the diabetics and 25.6% (SSE = 16.1) for the nondiabetics.
Abstract
Diabetes mellitus has been identified as a possible risk factor for tardive dyskinesia. The authors examined 160 elderly individuals who were beginning neuroleptic treatment; 24 had diabetes and 136 did not. After 43 weeks of neuroleptic exposure, the cumulative incidence rates of tardive dyskinesia were 54.1% (SE = 5.6%) for the diabetics and 25.6% (SE = 16.1%) for the nondiabetics.
Keywords
Medicine
Archives of General PsychiatryTardive Dyskinesia
657 Citations1982John M. Kane
Prevalence surveys of tardive dyskinesia in neuroleptic-treated patients are reviewed and it is suggested that advancing age and female sex are the two variables most consistently associated with increased prevalence.
JAMAProspective Study of Tardive Dyskinesia Incidence in the Elderly
173 Citations1991Bruce L. Saltz
Investigation of the incidence of tardive dyskinesia in elderly individuals beginning treatment with antipsychotic drugs found psychiatric (as opposed to organic) diagnosis and presence of extrapyramidal signs early in treatment were associated with increased tardiv dyskine vulnerability.
Journal of Clinical PsychopharmacologyThe Prevalence of Tardive Dyskinesia
147 Citations1991Margaret G. Woerner, John M. Kane +9 more
Logistic regression analyses revealed a large effect of age on tardive dyskinesia prevalence and an interaction of age with sex, and among younger subjects, men had higher rates; among subjects over age 40, rates were higher for women.
ScienceGlucose Suppresses Basal Firing and Haloperidol-Induced Increases in the Firing Rate of Central Dopaminergic Neurons
146 Citations1980Charles Saller, Louis A. Chiodo
In the rat, doses of glucose sufficient to raise glucose concentrations in the blood to levels equivalent to those produced by a meal or stress suppress the firing of dopamine-containing neurons located within the substantia nigra.
Archives of General PsychiatryThe Prevalence of Tardive Dyskinesia in Neuroleptic-Treated Diabetics
93 Citations1991Linda Ganzini
Neuroleptic-treated diabetics had a significantly higher prevalence and severity of tardive dyskinesia, and it is suggested that diabetes mellitus should be examined further as a risk factor for tardiv dysKinesia.
NeurologyHemichorea‐hemiballism and lacunar infarction in the basal ganglia
57 Citations1981Carlos S. Kase, Gilbert O. Maulsby +2 more
A case of acute hemichorea-hemiballism associated with lacunar infarct documented by computerized tomography scan in the contralateral putamen and caudate nuclei is presented.
Archives of NeurologyChorea Caused by Caudate Infarction
52 Citations1983Stephen C. Saris
An ischemic infarct in the caudate nucleus was associated with a contralateral chorea in a 47-year-old, hypertensive, diabetic man and this is only the second report of isolated caudates infarction associated with chorea.
Archives of General PsychiatryPossible Association Between Tardive Dyskinesia and Altered Carbohydrate Metabolism
30 Citations1985Sukdeb Mukherjee
In reviewing the medical records of 35 patients who fulfilled research criteria for persistent terdive dyskinesia (TD), it was found that five patients (14%) had diabetes mellitus (DM), and the prevalence of DM was in excess of the expected population prevalence of 1% to 2% in both samples.
Drug Development ResearchTardive dyskinesias and drugs
17 Citations1986John M. Kane, Margaret G. Woerner +2 more
The incidence of tardive dyskine‐sia among relatively young patients of varying diagnoses exposed to neuroleptics appears to be approximately 3–4% per year of cumulative neuroleptic exposure, at least for the first 6 years of such treatment.